Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region
- PMID: 38245105
- DOI: 10.1016/S2214-109X(23)00600-9
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region
Conflict of interest statement
NJD has received research funding from Gilead Sciences for an unrelated project. BRB has received research funding, honoraria, and travel expenses from Gilead Sciences and ViiV Healthcare for unrelated projects.
Comment on
-
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.Lancet Glob Health. 2024 Feb;12(2):e243-e256. doi: 10.1016/S2214-109X(23)00536-3. Lancet Glob Health. 2024. PMID: 38245115
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
